Figure 2From: Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol Summary of key practical aspects of the Clinical Evaluation of the DOSe of Erythropoietin (C.E.DOSE) trial.Back to article page